🔎 Trials Near Me

Dachaigh › Cancer Ovarian › Louisiana › New Orleans

Sgrùdaidhean clionaigeach Cancer Ovarian ann an New Orleans, LA

Tha 12 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air New Orleans (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

A’ fastadhÌre 3
  • Louisiana State University HSC - NO Cancer Center, New Orleans
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 5 Dàmh 2026 · NCT06915025

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

A’ fastadhÌre 2/3
  • University Medical Center New Orleans, New Orleans
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

A’ fastadhÌre 2
  • Ochsner Medical Center Jefferson, New Orleans
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564377

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

A’ fastadhSgrùdadh amharc
  • Ochsner Clinic Foundation, New Orleans
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05051722

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

A’ fastadhÌre 3
  • Ochsner Clinic Foundation, New Orleans
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213804

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A’ fastadhSgrùdadh amharc
  • Tulane Cancer Center, New Orleans
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05059444

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

A’ fastadh
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • West Jefferson Medical Center, Marrero · 4 mìle air falbh
Aoisean 35 gu 50 · Banairean · Air ùrachadh 7 Lùna 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

A’ fastadhÌre 3
  • University Medical Center New Orleans, New Orleans
  • Ochsner Baptist Medical Center, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06580314

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

A’ fastadhÌre 3
  • LSU Health New Orleans, New Orleans
  • University Medical Center New Orleans, New Orleans
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 16 Gibl 2026 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, New Orleans
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Sgrùdaidhean Cancer Ovarian ann am bailtean eile

Sgrùdaidhean eile ann an New Orleans

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.